» Articles » PMID: 38006345

Comparison of Acceptability & Efficacy of Thermal Ablation (thermocoagulation) & Cryotherapy in VIA Positive Cervical Lesions: A Pilot Study

Overview
Specialty General Medicine
Date 2023 Nov 25
PMID 38006345
Authors
Affiliations
Soon will be listed here.
Abstract

Background Objectives: The World Health Organization (WHO) has endorsed thermal ablation (thermocoagulation) as an efficient and safe modality for treatment of cervical pre-cancer lesions. More evidence is being looked up by WHO through rigorous studies for health delivery models using screen-and-treat strategies incorporating thermal ablation and studies comparing it against the conventional standard modality cryotherapy. The objective of this study was to assess the acceptability of thermal ablation both among the providers and clients and compare the same with cryotherapy.

Methods: A randomized control trial was conducted for one year from September 2019 to October 2020 after obtaining ethics approval. Computer-generated random number table was used for randomization, and eligible candidates were divided into two groups following informed consent. Women with visual inspection with acetic acid (VIA) positive cervical lesions in Group A received cryotherapy and Group B received thermal ablation. After the procedure, the acceptability of the provider and the client were assessed using the International Agency for Research on Cancer-validated questionnaire for both the procedures. Immediate side effects and problems at six weeks and at six months were assessed as well. Efficacy was decided by the absence of VIA positivity at six months.

Results: The overall VIA positivity in this study was 11.8 per cent. Thermal ablation (thermocoagulation) had better provision and client acceptability than cryotherapy (significant difference). The efficacy of thermal ablation was 97.6 per cent, while, it was 92 per cent for cryotherapy (not significant).

Interpretation Conclusions: In the context of screen-and-treat programme in settings such as India, thermal ablation appears to be a better method of treatment than cryotherapy for cervical pre-cancerous lesions particularly in terms of better provision and client acceptability.

Citing Articles

Drugs and drug targets for the treatment of HPV-positive cervical cancer.

Burmeister C, Khan S, Prince S Tumour Virus Res. 2024; 19():200309.

PMID: 39709045 PMC: 11733058. DOI: 10.1016/j.tvr.2024.200309.

References
1.
Bhatla N, Gulati A, Mathur S, Rani S, Anand K, Muwonge R . Evaluation of cervical screening in rural North India. Int J Gynaecol Obstet. 2009; 105(2):145-9. DOI: 10.1016/j.ijgo.2008.12.010. View

2.
Sankaranarayanan R, Nessa A, Esmy P, Dangou J . Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2011; 26(2):221-32. DOI: 10.1016/j.bpobgyn.2011.08.003. View

3.
Chigbu C, Onwudiwe E, Onyebuchi A . Thermo-coagulation versus cryotherapy for treatment of cervical precancers: A prospective analytical study in a low-resource African setting. J Obstet Gynaecol Res. 2019; 46(1):147-152. DOI: 10.1111/jog.14139. View

4.
. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet. 1999; 353(9156):869-73. View

5.
Paul P, Winkler J, Bartolini R, Penny M, Huong T, Nga L . Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. Oncologist. 2013; 18 Suppl:6-12. DOI: 10.1634/theoncologist.18-S2-6. View